Foto del docente

Laura Menotti

Associate Professor

Department of Pharmacy and Biotechnology

Academic discipline: BIO/19 Microbiology


Appolloni I.; Alessandrini F.; Menotti L.; Avitabile E.; Marubbi D.; Piga N.; Ceresa D.; Piaggio F.; Campadelli-Fiume G.; Malatesta P., Specificity, safety, efficacy of egfrviii-retargeted oncolytic hsv for xenotransplanted human glioblastoma, «VIRUSES», 2021, 13, pp. 1677 - 1689 [Scientific article]Open Access

Menotti L.; Avitabile E., Herpes simplex virus oncolytic immunovirotherapy: The blossoming branch of multimodal therapy, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2020, 21, Article number: 8310 , pp. 1 - 26 [Scientific article]Open Access

Laura Menotti, Valerio Leoni, Valentina Gatta, Biljana Petrovic, Andrea Vannini, Simona Pepe, Tatiana Gianni, Gabriella Campadelli-Fiume, oHSV Genome Editing by Means of galK Recombineering, in: Herpes Simplex Virus, New York, NY, Humana Press, 2020, pp. 131 - 151 (METHODS IN MOLECULAR BIOLOGY) [Chapter or essay]Open Access

Andrea Vannini, Biljana Petrovic, Valentina Gatta, Valerio Leoni, Simona Pepe, Laura Menotti, Gabriella Campadelli-Fiume, Tatiana Gianni, Rescue, Purification, and Characterization of a Recombinant HSV Expressing a Transgenic Protein, in: Herpes Simplex Virus, New York, NY, Humana Press, 2020, pp. 153 - 168 (METHODS IN MOLECULAR BIOLOGY) [Chapter or essay]Open Access

Alessandrini, Francesco; Menotti, Laura; Avitabile, Elisa; Appolloni, Irene; Ceresa, Davide; Marubbi, Daniela; Campadelli-Fiume, Gabriella; Malatesta, Paolo, Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model, «ONCOGENE», 2019, 38, pp. 4467 - 4479 [Scientific article]Open Access

Menotti, Laura; Avitabile, Elisa; Gatta, Valentina; Malatesta, Paolo; Petrovic, Biljana; Campadelli-Fiume, Gabriella, HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses, «VIRUSES», 2018, 10, Article number: 352 , pp. 1 - 29 [Scientific article]Open Access

P. Nanni; V. Gatta; L. Menotti; C. De Giovanni; M. Ianzano; A. Palladini; V. Grosso; M. Dall’Ora; S. Croci; G. Nicoletti; L. Landuzzi; M. Iezzi; G. Campadelli-Fiume; P.-L. Lollini., Preclinical therapy of disseminated HER-2+ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus., «PLOS PATHOGENS», 2013, 9, Article number: e1003155 , pp. 1 - 10 [Scientific article]Open Access

Reisoli E.; Gambini E.; Appolloni I.; Gatta V.; Barilari M.; Menotti L.; Malatesta P., Efficacy of HER2 retargeted herpes simplex virus as therapy for high-grade glioma in immunocompetent mice., «CANCER GENE THERAPY», 2012, 19, pp. 788 - 795 [Scientific article]

Campadelli-Fiume G.; Menotti L.; Zhou G.; De Giovanni C.; Nanni P.; Lollini P.-L., Herpesviruses as oncolytic agents, in: From the Hallowed Halls of Herpesvirology. A Tribute to Bernard Roizman, Singapore 596224, World Scientific Publishing Co. Pte. Ltd., 2012, pp. 223 - 250 [Chapter or essay]

Gambini E.; Reisoli E.; Appolloni I.; Gatta V.; Campadelli-Fiume G.; Menotti L.; Malatesta P., Replication-competent herpes simplex virus retargeted to HER2 as therapy for high-grade glioma, «MOLECULAR THERAPY», 2012, 20, pp. 994 - 1001 [Scientific article]

Menotti L.; Campadelli-Fiume G.; Nanni P.; Lollini P.-L.; De Giovanni C., The molecular basis of herpesviruses as oncolytic agents., «CURRENT PHARMACEUTICAL BIOTECHNOLOGY», 2012, 13, pp. 1795 - 1803 [Scientific article]

Campadelli-Fiume G.; Menotti L.; Avitabile E.; Gianni T., Viral and cellular contributions to herpes simplex virus entry into the cell, «CURRENT OPINION IN VIROLOGY», 2012, 2, pp. 28 - 36 [Scientific article]

G. Campadelli-Fiume; C. De Giovanni; V. Gatta; P. Nanni; P.L. Lollini; L. Menotti, Rethinking herpes simplex virus: the way to oncolytic agents., «REVIEWS IN MEDICAL VIROLOGY», 2011, 21, pp. 213 - 226 [Scientific article]

Menotti L.; Nicoletti G.; Gatta V.; Croci S.; Landuzzi L.; De Giovanni C.; Nanni P.; Lollini P.L.; Campadelli-Fiume G., Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells., «PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA», 2009, 106, pp. 9039 - 9044 [Scientific article]

Lollini P.L.; Menotti L.; De Giovanni C.; Campadelli-Fiume G.; Nanni P., Oncolytic herpes virus retargeted to HER-2., «CELL CYCLE», 2009, 8, pp. 2859 - 2860 [Scientific article]

Latest news

At the moment no news are available.